Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
about
Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical studyEffect of simvastatin and atorvastatin on serum vitamin d and bone mineral density in hypercholesterolemic patients: a cross-sectional study.Statins and osteoporosis: new role for old drugs.Pleiotropic effects of the HMG-CoA reductase inhibitorsLocal low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.Statins and vitamin D.Efficacy of statins for osteoporosis: a systematic review and meta-analysis.Statins and hip fracture prevention--a population based cohort study in womenCalcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study.Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritisSpinal and paraspinal lesions: the role of stereotactic body radiotherapy.Effects of Statins on Bone Mineral Density and Fracture Risk: A PRISMA-compliant Systematic Review and Meta-AnalysisNo effect of switching to high-dose rosuvastatin, add-on nicotinic acid, or add-on fenofibrate on serum vitamin D levels in patients with mixed dyslipidemiaSimvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialThe pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review.An old friend in a new light: the role of osteocalcin in energy metabolism.Should we abandon statins in the prevention of bone fractures?Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients.The effects of atorvastatin on the prevention of osteoporosis and dyslipidemia in the high-fat-fed ovariectomized rats.Simvastatin exerts antiproliferative and differentiating effects on MG63 osteoblast-like cells: Morphological and immunocytochemical study.Bone mineral density in statin users: a population-based analysis from a Spanish cohort.Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.
P2860
Q33649834-B2FAFBE8-1132-45DD-8F51-7D19D634A726Q34100680-687C0563-45EC-4052-B739-B326F9299958Q34563901-98A3042B-FC50-4F19-90E3-2CF626AA2520Q34894749-0C129503-1BFE-487D-A873-6BD403D5B56AQ35157847-30A49227-F923-4728-B74C-16CFCAB26301Q36138240-1E1BA60F-38F0-447C-92D8-37B63CFA1462Q36204400-B3A64109-C7E1-477E-BD23-8C89D927953FQ36353931-59E316F8-33B2-480B-9BA0-59BC6555B58BQ36454701-87B6484A-20A9-43D9-BD1A-E22296E49FE3Q36633407-BB4EA373-5C72-466B-BD77-7EEFFF836672Q36887077-C2B26F2B-6AF8-484A-8364-71562F6CE021Q36988655-6762DC56-E7F1-4B0D-828D-8F439CA8CBC8Q37078453-1BE3DDD4-F41F-4C02-9A72-97A82BDAE25CQ37423170-BE6E0625-4B11-4DC9-842A-658A46D51511Q37909189-0CBB9C28-4852-4D85-9E1E-398297FE310AQ37942705-4339D263-8155-4E0A-A89F-7F6D1AFD91C3Q38092753-8374A175-6E83-4994-A2CA-B53D63137008Q40105699-C195DBCB-936B-4B6B-BF4C-CAD325B0D653Q47729932-714E76E5-6CF2-4B40-B7D6-277963BB1F3CQ48134962-68B4FDDA-CF37-4405-BCDB-87AF3E3BFF02Q50489504-84996834-5520-47B4-BA31-2F845D2A1CA6Q55472823-7C09DAE8-0932-454A-821C-A518C4EF4DD9
P2860
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
@ast
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
@en
type
label
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
@ast
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
@en
prefLabel
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
@ast
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
@en
P1476
Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis
@en
P2093
Christos Hatzigeorgiou
P2860
P2888
P304
P356
10.1007/S00198-004-1793-0
P407
P50
P577
2005-03-03T00:00:00Z